BioNeutra Global Corporation Share Price

Equities

BGA

CA09073L1067

Food Processing

Market Closed - Toronto S.E. 01:25:49 20/04/2024 am IST 5-day change 1st Jan Change
0.1 CAD -4.76% Intraday chart for BioNeutra Global Corporation 0.00% +400.00%

Financials

Sales 2022 13.39M 9.79M 817M Sales 2023 11.38M 8.32M 694M Capitalization 934K 683K 56.96M
Net income 2022 -2M -1.46M -122M Net income 2023 -2M -1.46M -122M EV / Sales 2022 0.54 x
Net Debt 2022 6.28M 4.59M 383M Net Debt 2023 5.75M 4.2M 351M EV / Sales 2023 0.59 x
P/E ratio 2022
-0.32 x
P/E ratio 2023
-0.4 x
Employees -
Yield 2022 *
-
Yield 2023
-
Free-Float 63.14%
More Fundamentals * Assessed data
Dynamic Chart
BioNeutra Global Corporation Reports Earnings Results for the Full Year Ended December 31, 2023 CI
BioNeutra Global Corporation Appoints Stephen Jakeway as Chief Operating Officer CI
BioNeutra Global Corporation Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023 CI
BioNeutra Global Corporation Appoints Mr. Bill Smith to the Board of Directors CI
BioNeutra Global Corporation Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023 CI
BioNeutra Global Corporation Announces Executive Changes CI
BioNeutra Global Corporation Reports Earnings Results for the First Quarter Ended March 31, 2023 CI
BioNeutra Global Corporation Reports Earnings Results for the Full Year Ended December 31, 2022 CI
BioNeutra Global Corporation Auditor Raises 'Going Concern' Doubt CI
BioNeutra Global Corporation Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022 CI
BioNeutra Global Corporation Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022 CI
BioNeutra Global Corporation Reports Earnings Results for the First Quarter Ended March 31, 2022 CI
BioNeutra Global Corporation Reports Earnings Results for the Full Year Ended December 31, 2021 CI
BioNeutra Global Corporation Auditor Raises 'Going Concern' Doubt CI
BioNeutra Global Corporation Announces Change of Chief Financial Officer CI
More news
1 day-4.76%
Current month+11.11%
1 month-16.67%
3 months+566.67%
6 months+400.00%
Current year+400.00%
More quotes
1 month
0.10
Extreme 0.095
0.15
Current year
0.02
Extreme 0.015
0.16
1 year
0.01
Extreme 0.005
0.16
3 years
0.01
Extreme 0.005
0.27
5 years
0.01
Extreme 0.005
0.55
10 years
0.01
Extreme 0.005
0.95
More quotes
Managers TitleAgeSince
Founder - 08/96/08
Director of Finance/CFO - 10/21/10
Chief Tech/Sci/R&D Officer - -
Members of the board TitleAgeSince
Director/Board Member - 06/19/06
Chairman - 29/14/29
Director/Board Member 66 23/23/23
More insiders
Date Price Change Volume

Delayed Quote Toronto S.E., April 20, 2024 at 01:25 am IST

More quotes
BioNeutra Global Corporation, through its subsidiaries, is involved in the research and development, production and commercialization of food ingredients for nutraceutical, functional and mainstream foods, with a focus on oligosaccharides. Its lead product, VitaFiber IMO is an advanced functional and health food ingredient naturally derived from agricultural products. VitaFiber IMO is naturally sweet and lower in calories than sugar and is a natural source of dietary fiber as it provides low calorie soluble prebiotic fiber for human digestive health. The Company produces VitaFiber IMO using its patented production processes that naturally transform starch molecules from agriculture cereal crops including tapioca, field pea or corn into the functional health molecules of isomalto-oligosaccharide (IMO). VitaFiber IMO is also available for retail purchase across the globe through Amazon.com and Shopify.com. Its customers include small and medium enterprises and food manufacturers.
More about the company